Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy

Low plasma levels of branched chain amino acids (BCAA) in liver cirrhosis are associated with hepatic encephalopathy (HE). We aimed to identify a metabolic signature of minimal hepatic encephalopathy (MHE) in malnourished cirrhotic patients and evaluate its modification with oral nutritional supplem...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Silvia Espina, Yolanda Gonzalez-Irazabal, Alejandro Sanz-Paris, Marta Lopez-Yus, Maria Pilar Garcia-Sobreviela, Raquel del Moral-Bergos, Beatriz Garcia-Rodriguez, Javier Fuentes-Olmo, Vanesa Bernal-Monterde, Jose M. Arbones-Mainar
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
HMB
PCA
Acceso en línea:https://doaj.org/article/bceaefe8a6ae454fb1e481e9a14d8381
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bceaefe8a6ae454fb1e481e9a14d8381
record_format dspace
spelling oai:doaj.org-article:bceaefe8a6ae454fb1e481e9a14d83812021-11-25T18:33:51ZAmino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy10.3390/nu131137642072-6643https://doaj.org/article/bceaefe8a6ae454fb1e481e9a14d83812021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/3764https://doaj.org/toc/2072-6643Low plasma levels of branched chain amino acids (BCAA) in liver cirrhosis are associated with hepatic encephalopathy (HE). We aimed to identify a metabolic signature of minimal hepatic encephalopathy (MHE) in malnourished cirrhotic patients and evaluate its modification with oral nutritional supplements (ONS) enriched with ß-Hydroxy-ß-methylbutyrate (HMB), a derivative of the BCAA leucine. Post hoc analysis was conducted on a double-blind placebo-controlled trial of 43 individuals with cirrhosis and malnutrition, who were randomized to receive, for 12 weeks, oral supplementation twice a day with either 220 mL of Ensure<sup>®</sup> Plus Advance (HMB group, <i>n</i> = 22) or with 220 mL of Ensure<sup>®</sup> Plus High Protein (HP group, <i>n</i> = 21). MHE evaluation was by psychometric hepatic encephalopathy score (PHES). Compared to the HP group, an HMB-specific treatment effect led to a larger increase in Val, Leu, Phe, Trp and BCAA fasting plasma levels. Both treatments increased Fischer’s ratio and urea without an increase in Gln or ammonia fasting plasma levels. MHE was associated with a reduced total plasma amino acid concentration, a reduced BCAA and Fischer´s ratio, and an increased Gln/Glu ratio. HMB-enriched ONS increased Fischer´s ratio without varying Gln or ammonia plasma levels in liver cirrhosis and malnutrition, a protective amino acid profile that can help prevent MHE.Silvia EspinaYolanda Gonzalez-IrazabalAlejandro Sanz-ParisMarta Lopez-YusMaria Pilar Garcia-SobrevielaRaquel del Moral-BergosBeatriz Garcia-RodriguezJavier Fuentes-OlmoVanesa Bernal-MonterdeJose M. Arbones-MainarMDPI AGarticleHMBhydroxymethylbutyrateclinical trialPCANutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 3764, p 3764 (2021)
institution DOAJ
collection DOAJ
language EN
topic HMB
hydroxymethylbutyrate
clinical trial
PCA
Nutrition. Foods and food supply
TX341-641
spellingShingle HMB
hydroxymethylbutyrate
clinical trial
PCA
Nutrition. Foods and food supply
TX341-641
Silvia Espina
Yolanda Gonzalez-Irazabal
Alejandro Sanz-Paris
Marta Lopez-Yus
Maria Pilar Garcia-Sobreviela
Raquel del Moral-Bergos
Beatriz Garcia-Rodriguez
Javier Fuentes-Olmo
Vanesa Bernal-Monterde
Jose M. Arbones-Mainar
Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy
description Low plasma levels of branched chain amino acids (BCAA) in liver cirrhosis are associated with hepatic encephalopathy (HE). We aimed to identify a metabolic signature of minimal hepatic encephalopathy (MHE) in malnourished cirrhotic patients and evaluate its modification with oral nutritional supplements (ONS) enriched with ß-Hydroxy-ß-methylbutyrate (HMB), a derivative of the BCAA leucine. Post hoc analysis was conducted on a double-blind placebo-controlled trial of 43 individuals with cirrhosis and malnutrition, who were randomized to receive, for 12 weeks, oral supplementation twice a day with either 220 mL of Ensure<sup>®</sup> Plus Advance (HMB group, <i>n</i> = 22) or with 220 mL of Ensure<sup>®</sup> Plus High Protein (HP group, <i>n</i> = 21). MHE evaluation was by psychometric hepatic encephalopathy score (PHES). Compared to the HP group, an HMB-specific treatment effect led to a larger increase in Val, Leu, Phe, Trp and BCAA fasting plasma levels. Both treatments increased Fischer’s ratio and urea without an increase in Gln or ammonia fasting plasma levels. MHE was associated with a reduced total plasma amino acid concentration, a reduced BCAA and Fischer´s ratio, and an increased Gln/Glu ratio. HMB-enriched ONS increased Fischer´s ratio without varying Gln or ammonia plasma levels in liver cirrhosis and malnutrition, a protective amino acid profile that can help prevent MHE.
format article
author Silvia Espina
Yolanda Gonzalez-Irazabal
Alejandro Sanz-Paris
Marta Lopez-Yus
Maria Pilar Garcia-Sobreviela
Raquel del Moral-Bergos
Beatriz Garcia-Rodriguez
Javier Fuentes-Olmo
Vanesa Bernal-Monterde
Jose M. Arbones-Mainar
author_facet Silvia Espina
Yolanda Gonzalez-Irazabal
Alejandro Sanz-Paris
Marta Lopez-Yus
Maria Pilar Garcia-Sobreviela
Raquel del Moral-Bergos
Beatriz Garcia-Rodriguez
Javier Fuentes-Olmo
Vanesa Bernal-Monterde
Jose M. Arbones-Mainar
author_sort Silvia Espina
title Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy
title_short Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy
title_full Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy
title_fullStr Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy
title_full_unstemmed Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy
title_sort amino acid profile in malnourished patients with liver cirrhosis and its modification with oral nutritional supplements: implications on minimal hepatic encephalopathy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/bceaefe8a6ae454fb1e481e9a14d8381
work_keys_str_mv AT silviaespina aminoacidprofileinmalnourishedpatientswithlivercirrhosisanditsmodificationwithoralnutritionalsupplementsimplicationsonminimalhepaticencephalopathy
AT yolandagonzalezirazabal aminoacidprofileinmalnourishedpatientswithlivercirrhosisanditsmodificationwithoralnutritionalsupplementsimplicationsonminimalhepaticencephalopathy
AT alejandrosanzparis aminoacidprofileinmalnourishedpatientswithlivercirrhosisanditsmodificationwithoralnutritionalsupplementsimplicationsonminimalhepaticencephalopathy
AT martalopezyus aminoacidprofileinmalnourishedpatientswithlivercirrhosisanditsmodificationwithoralnutritionalsupplementsimplicationsonminimalhepaticencephalopathy
AT mariapilargarciasobreviela aminoacidprofileinmalnourishedpatientswithlivercirrhosisanditsmodificationwithoralnutritionalsupplementsimplicationsonminimalhepaticencephalopathy
AT raqueldelmoralbergos aminoacidprofileinmalnourishedpatientswithlivercirrhosisanditsmodificationwithoralnutritionalsupplementsimplicationsonminimalhepaticencephalopathy
AT beatrizgarciarodriguez aminoacidprofileinmalnourishedpatientswithlivercirrhosisanditsmodificationwithoralnutritionalsupplementsimplicationsonminimalhepaticencephalopathy
AT javierfuentesolmo aminoacidprofileinmalnourishedpatientswithlivercirrhosisanditsmodificationwithoralnutritionalsupplementsimplicationsonminimalhepaticencephalopathy
AT vanesabernalmonterde aminoacidprofileinmalnourishedpatientswithlivercirrhosisanditsmodificationwithoralnutritionalsupplementsimplicationsonminimalhepaticencephalopathy
AT josemarbonesmainar aminoacidprofileinmalnourishedpatientswithlivercirrhosisanditsmodificationwithoralnutritionalsupplementsimplicationsonminimalhepaticencephalopathy
_version_ 1718410975231606784